Varroc Engineering Limited (NSE:VARROC)
India · Delayed Price · Currency is INR 536.80
+20.80 (4.03%)
Aug 5, 2025, 1:30 PM IST
Sage Therapeutics Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Net Income | 612.3 | 5,260 | -8,198 | -11,099 | -6,319 | Upgrade |
Depreciation & Amortization | 2,999 | 3,075 | 3,023 | 6,802 | 6,127 | Upgrade |
Other Amortization | 234.35 | 293.66 | 344.7 | 2,936 | 2,824 | Upgrade |
Loss (Gain) From Sale of Assets | -26.32 | -64.29 | -76.37 | 11.82 | -230.02 | Upgrade |
Loss (Gain) From Sale of Investments | -36.58 | -18.75 | -0.09 | -1.44 | -1.38 | Upgrade |
Loss (Gain) on Equity Investments | -37.09 | -443.96 | -53.28 | 4.33 | -356.28 | Upgrade |
Provision & Write-off of Bad Debts | 6.95 | 220.28 | 250.36 | 149 | 84.27 | Upgrade |
Other Operating Activities | 4,153 | -992.62 | 11,512 | 11,945 | 8,257 | Upgrade |
Change in Accounts Receivable | -1,883 | 840.94 | -253.93 | -1,068 | -5,323 | Upgrade |
Change in Inventory | -551.7 | -23.5 | -676.81 | -1,675 | -1,248 | Upgrade |
Change in Accounts Payable | 1,520 | 272.06 | -3,680 | 5,525 | 5,907 | Upgrade |
Change in Other Net Operating Assets | 377.07 | -1,914 | 7,519 | 3,174 | 1,264 | Upgrade |
Operating Cash Flow | 7,367 | 6,385 | 6,862 | 6,356 | 4,737 | Upgrade |
Operating Cash Flow Growth | 15.39% | -6.95% | 7.96% | 34.17% | -66.49% | Upgrade |
Capital Expenditures | -2,788 | -2,574 | -5,306 | -6,537 | -5,611 | Upgrade |
Sale of Property, Plant & Equipment | 167.74 | 557.85 | 276.6 | 99.4 | 474.41 | Upgrade |
Cash Acquisitions | - | - | - | - | -78.59 | Upgrade |
Sale (Purchase) of Intangibles | -100.91 | -168.16 | -675.8 | -1,999 | -2,141 | Upgrade |
Investment in Securities | 207.52 | -732.57 | -526.71 | 77.46 | 58.47 | Upgrade |
Other Investing Activities | 50.39 | 1,252 | 3,376 | 733.27 | 857.62 | Upgrade |
Investing Cash Flow | -2,463 | -1,665 | -2,856 | -7,625 | -6,440 | Upgrade |
Short-Term Debt Issued | 1,806 | - | 728.07 | - | - | Upgrade |
Long-Term Debt Issued | 45.73 | 4,500 | 7,065 | 5,723 | 5,720 | Upgrade |
Total Debt Issued | 1,851 | 4,500 | 7,794 | 5,723 | 5,720 | Upgrade |
Short-Term Debt Repaid | - | -553.03 | - | -1,256 | -9,310 | Upgrade |
Long-Term Debt Repaid | -5,044 | -8,462 | -7,753 | -7,931 | -3,207 | Upgrade |
Total Debt Repaid | -5,044 | -9,015 | -7,753 | -9,187 | -12,517 | Upgrade |
Net Debt Issued (Repaid) | -3,192 | -4,515 | 40.14 | -3,463 | -6,797 | Upgrade |
Issuance of Common Stock | - | - | - | - | 6,852 | Upgrade |
Other Financing Activities | -1,712 | -2,126 | -2,200 | 114.84 | -1,576 | Upgrade |
Financing Cash Flow | -4,904 | -6,641 | -2,160 | -3,349 | -1,522 | Upgrade |
Foreign Exchange Rate Adjustments | 10.95 | 2.54 | -98.98 | 5.52 | 307.62 | Upgrade |
Miscellaneous Cash Flow Adjustments | - | - | -1,525 | - | - | Upgrade |
Net Cash Flow | 10.41 | -1,919 | 221.21 | -4,612 | -2,917 | Upgrade |
Free Cash Flow | 4,579 | 3,810 | 1,556 | -180.94 | -873.48 | Upgrade |
Free Cash Flow Growth | 20.18% | 144.89% | - | - | - | Upgrade |
Free Cash Flow Margin | 5.62% | 5.05% | 2.26% | -0.31% | -2.00% | Upgrade |
Free Cash Flow Per Share | 29.97 | 24.94 | 10.18 | -1.18 | -6.46 | Upgrade |
Cash Interest Paid | 1,712 | 2,079 | 2,633 | 1,758 | 1,576 | Upgrade |
Cash Income Tax Paid | -91.32 | 557.19 | 920.66 | 735.68 | 197.5 | Upgrade |
Levered Free Cash Flow | -998.87 | 980.89 | 10,387 | -13,830 | 3,613 | Upgrade |
Unlevered Free Cash Flow | 31.58 | 2,134 | 11,500 | -13,133 | 4,152 | Upgrade |
Change in Net Working Capital | 3,146 | 1,130 | -12,491 | 14,926 | -2,318 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.